For research use only. Not for therapeutic Use.
CAY 10434 dihydrochloride is a potent CYP4A hydroxylase inhibitor. CAY 10434 dihydrochloride improves contractile response to angiotensin II with the maximal contractile response (Emax) 6764 mg[1].
CAY 10434 dihydrochloride (1 µM; 30 min) combines micoanzol to increase the cumulative angiotensin II in endothelium-intact aortic rings [1].
| Catalog Number | R010216 |
| CAS Number | 502656-68-0 |
| Synonyms | 6-(4-imidazol-1-ylphenoxy)-N,N-dimethylhexan-1-amine;dihydrochloride |
| Molecular Formula | C17H27Cl2N3O |
| Purity | ≥95% |
| InChI | InChI=1S/C17H25N3O.2ClH/c1-19(2)12-5-3-4-6-14-21-17-9-7-16(8-10-17)20-13-11-18-15-20;;/h7-11,13,15H,3-6,12,14H2,1-2H3;2*1H |
| InChIKey | SRCWAJONAASSNJ-UHFFFAOYSA-N |
| SMILES | CN(C)CCCCCCOC1=CC=C(C=C1)N2C=CN=C2.Cl.Cl |
| Reference | [1]. Jerez S, et al. 17-Octadecynoic acid improves contractile response to angiotensin II by releasing vasocontrictor prostaglandins. Prostaglandins Other Lipid Mediat. 2012 Jan;97(1-2):36-42. |
